- Home
- AXSM vs KFY Comparison
AXSM vs KFY Comparison
Compare AXSM & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | KFY |
|---|---|---|
| Founded | 2012 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 3.4B |
| IPO Year | 2015 | 1999 |
Fundamental Metrics
Financial Performance| Metric | AXSM | KFY |
|---|---|---|
| Price | $152.83 | $68.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 3 |
| Target Price | ★ $176.00 | $78.00 |
| AVG Volume (30 Days) | 471.7K | ★ 514.2K |
| Earning Date | 11-03-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | N/A | ★ 5.12 |
| EPS | N/A | ★ 4.91 |
| Revenue | $561,263,000.00 | ★ $2,811,089,000.00 |
| Revenue This Year | $66.20 | $4.54 |
| Revenue Next Year | $57.56 | $4.41 |
| P/E Ratio | ★ N/A | $14.11 |
| Revenue Growth | ★ 65.83 | 3.78 |
| 52 Week Low | $75.56 | $59.23 |
| 52 Week High | $152.94 | $78.50 |
Technical Indicators
Market Signals| Indicator | AXSM | KFY |
|---|---|---|
| Relative Strength Index (RSI) | 63.00 | 57.08 |
| Support Level | $145.07 | $68.28 |
| Resistance Level | $149.13 | $69.77 |
| Average True Range (ATR) | 4.48 | 1.45 |
| MACD | -0.41 | 0.34 |
| Stochastic Oscillator | 87.81 | 65.97 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.